• 2022-07-28 问题

    Propranolol (普萘洛尔) belongs to A: α receptor antagonist B: α receptor agonist C: β receptor antagonist D: β receptor agonist

    Propranolol (普萘洛尔) belongs to A: α receptor antagonist B: α receptor agonist C: β receptor antagonist D: β receptor agonist

  • 2022-07-28 问题

    Propranolol is a A: M3 receptor agonist B: α receptor agonist C: β receptor antagonist D: α receptor antagonist E: NM receptor antagonist

    Propranolol is a A: M3 receptor agonist B: α receptor agonist C: β receptor antagonist D: α receptor antagonist E: NM receptor antagonist

  • 2022-06-06 问题

    A drug combine with the receptors and show its effects, the drug is called A: partial agonist B: agonist C: noncompetitive antagonist D: competitive antagonist E: blocker

    A drug combine with the receptors and show its effects, the drug is called A: partial agonist B: agonist C: noncompetitive antagonist D: competitive antagonist E: blocker

  • 2022-05-31 问题

    The concentration or dose at which drugs produce equivalent effects is called A: efficacy B: potency C: excitation D: inhibition E: agonist

    The concentration or dose at which drugs produce equivalent effects is called A: efficacy B: potency C: excitation D: inhibition E: agonist

  • 2022-07-28 问题

    Propranolol is A: effective in the treatment of supraventricular arrhythmias B: effective in all angina pectoris cases by increasing the O2 supply C: lowers the blood pressure by reducing the renin synthesis D: cardioselective and having a partial agonist activity

    Propranolol is A: effective in the treatment of supraventricular arrhythmias B: effective in all angina pectoris cases by increasing the O2 supply C: lowers the blood pressure by reducing the renin synthesis D: cardioselective and having a partial agonist activity

  • 2022-06-18 问题

    A 65-year-old woman is noted to have suspected uterine fibroids on physical examination. Over the course of 1 year, she is noted to have enlargement of her uterus from approximately 12 weeks’ size to 20 weeks’ size. Which of the following is the best management? () A: Continued careful observation B: Monitoring with ultrasound examinations C: Exploratory laparotomy with hysterectomy D: Gonadotropin-releasing hormone agonist E: Progestin therapy

    A 65-year-old woman is noted to have suspected uterine fibroids on physical examination. Over the course of 1 year, she is noted to have enlargement of her uterus from approximately 12 weeks’ size to 20 weeks’ size. Which of the following is the best management? () A: Continued careful observation B: Monitoring with ultrasound examinations C: Exploratory laparotomy with hysterectomy D: Gonadotropin-releasing hormone agonist E: Progestin therapy

  • 1